Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Faisal E. Almutairi"'
Autor:
Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Daniah AlMohammady, Amjaad Alfahed, Elaf F. Altebainawi, Mohammed Aldhaeefi, Hisham A. Badreldin, Ramesh Vishwakarma, Faisal E. Almutairi, Abeer A. Alenazi, Thamer Alsulaiman, Rahaf Ali Alqahtani, Fahad Al Dhahri, Namareq Aldardeer, Ahmed O. Alenazi, Shmeylan Al Harbi, Raed Kensara, Mai Alalawi, Khalid Al Sulaiman
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Dexamethasone usually recommended for patients with severe coronavirus disease 2019 (COVID-19) to reduce short-term mortality. However, it is uncertain if another corticosteroid, such as methylprednisolone, may be utilized to obta
Externí odkaz:
https://doaj.org/article/b7fe4e5cd2af4e15af7d79e9ac4300b2
Autor:
Rakan Faraj, Ahmed Alghanim, Rahaf Ali Alqahtani, Faisal E. Almutairi, Shmylan Alharbi, Hind Almodaimegh, Norah A. Alsumih, Turki Alsubeai
Publikováno v:
Journal of the Saudi Heart Association
Background Heart failure (HF) is a chronic disease affecting patients’ quality of life (QoL) and may cause depression. Recent studies reported that the prevalence of depression in patients with HF is 21.5%. Antidepressants, mainly selective seroton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a1cae8aae1fe53a89c54f77bf9dd9b8
http://europepmc.org/articles/PMC7640597
http://europepmc.org/articles/PMC7640597
Publikováno v:
Cureus
Aim To investigate the knowledge, attitudes, and practices of diabetes among Saudi adults in Riyadh. Methods A questionnaire-based study was carried out in September 2019. A previously validated questionnaire was used to assess participants' knowledg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f981325f112d8a683ddaa78855734c36
https://pubmed.ncbi.nlm.nih.gov/32064183
https://pubmed.ncbi.nlm.nih.gov/32064183
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 172
Direct qualitative methods that allow the rapid screening and identification of insulin products during early stages of the drug development process and those already in the market can be of great utility for manufacturers and regulatory agencies and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ec5c725a3be51e7ac0dc25fa7585b4
https://pubmed.ncbi.nlm.nih.gov/31096094
https://pubmed.ncbi.nlm.nih.gov/31096094